ProPhase Labs, Inc. (NASDAQ:PRPH) Short Interest Update

ProPhase Labs, Inc. (NASDAQ:PRPHGet Free Report) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 116,400 shares, an increase of 19.1% from the December 31st total of 97,700 shares. Based on an average daily trading volume, of 290,200 shares, the days-to-cover ratio is currently 0.4 days.

Analyst Ratings Changes

Separately, StockNews.com began coverage on shares of ProPhase Labs in a report on Saturday. They issued a “sell” rating for the company.

Get Our Latest Stock Analysis on ProPhase Labs

Institutional Trading of ProPhase Labs

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PRPH. Geode Capital Management LLC lifted its position in shares of ProPhase Labs by 9.2% during the third quarter. Geode Capital Management LLC now owns 160,735 shares of the company’s stock worth $389,000 after purchasing an additional 13,590 shares in the last quarter. HighTower Advisors LLC grew its holdings in ProPhase Labs by 18.3% during the 3rd quarter. HighTower Advisors LLC now owns 179,045 shares of the company’s stock worth $434,000 after acquiring an additional 27,673 shares in the last quarter. Finally, Sheets Smith Wealth Management acquired a new position in shares of ProPhase Labs during the fourth quarter worth $158,000. Hedge funds and other institutional investors own 9.45% of the company’s stock.

ProPhase Labs Stock Performance

Shares of PRPH stock opened at $0.26 on Monday. The company has a 50-day moving average of $0.65 and a two-hundred day moving average of $1.73. ProPhase Labs has a 1-year low of $0.26 and a 1-year high of $7.48. The company has a quick ratio of 1.33, a current ratio of 1.47 and a debt-to-equity ratio of 0.48.

ProPhase Labs Company Profile

(Get Free Report)

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.

Featured Articles

Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.